CARRIN CLIFFORD: Open Payments
NPI 1245945609 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,269 in 252 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $767 · 2025 $4,269
Food & beverage: $4,167Education: $102
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 119 | $1,085 |
| ABBVIE INC. | 30 | $902 |
| Lilly USA, LLC | 14 | $357 |
| PFIZER INC. | 20 | $292 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 25 | $285 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $226 |
| Madrigal Pharmaceuticals | 1 | $132 |
| Ardelyx, Inc. | 5 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| Amgen Inc. | 1 | $109 |
Products named: TREMFYA, SKYRIZI, VELSIPITY, LINZESS, RINVOQ, OMVOH, ENTYVIO, XIFAXAN.
Industry payments across NY — which companies pay providers there.
